Clinical Trial Update: PET Neuroimaging of [11C]Mirtazapine [Phase 4]

View source ↗

Summary

Phase 4 PET imaging study using radiolabeled [11C]mirtazapine to investigate brain binding in mood and depressive disorders; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Affective Disorder
• Depressive Disorder
• Mood Disorder

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: University of Aarhus | Conditions: Mental Disorders, Mood Disorders | Phase 4 | Status: COMPLETED